Anvisa Gives Green Light to SinoVac For Clinical Trials to Resume

Medicine & Technology Nov 12, 2020

SinoVac is the third pharmaceutical company to halt and resume clinical trials after a volunteer suffered a severe adverse event.

AstraZeneca's Vaccine Candidate Produces Antibodies and T-Cell Protection for Up to One Year

Oct 26, 2020

With AstraZeneca's vaccine trials resuming worldwide, results have shown good immune responses in young and older adults alike. However, trials are yet to resume in the United States as volunteers await their second dose.

Novavax To Begin Phase 3 of Trials, Hopes To Soon Combine COVID-19 and Flu Vaccines

Sep 25, 2020

Novavax's vaccine candidate has produced the highest number of antibodies according to vaccine experts. As they enter the final stage of human trials, they will also be testing some participants with the flu vaccine at the same time.

Johnson & Johnson Vaccine Candidate To Begin Phase 3 of Human Trials

Sep 24, 2020

Johnson & Johnson will be entering phase three of human trials, including 60,000 participants from three continents. They also continue to look for other possible treatments for coronavirus as their vaccine candidate completes safety and efficacy trials.

Vladamir Putin's Daughter Takes Part in Russia's Vaccine Trials

Aug 11, 2020

The Gamaleya vaccine is the first the receive regulatory approval in the world after two months of testing. Scientists around the world are skeptic, including the Association of Clinical Trials Organizations, of its efficacy and safety.